Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD). To improve our understanding of HCV‐mediated kidney dysfunction, we aimed to evaluate the baseline predictors of improvement in...

Full description

Bibliographic Details
Main Authors: Meghan E. Sise, Ian Strohbehn, Donald Chute, Kathleen E. Corey, Dahlene N. Fusco, Venkata S Sabbisetti, Sushrut S. Waikar, Raymond T. Chung
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2020-08-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1528

Internet

https://doi.org/10.1002/hep4.1528

Similar Items